CME

Faculty: Adam J. Luginbuhl, MD This online CME activity uses a patient–clinician dialogue format to explore the evolving role of perioperative immunotherapy in locally advanced head and neck squamous cell carcinoma (HNSCC). Expert commentary and patient-centered discussions address how to identify appropriate candidates based on disease stage, PD-L1 expression, resectability, and overall fitness f...

Faculty: Adam J. Luginbuhl, MD This online CME activity uses a patient–clinician dialogue format to explore the evolving role of perioperative immunotherapy in locally advanced head and neck squamous cell carcinoma (HNSCC). Expert commentary and patient-centered discussions address how to identify appropriate candidates based on disease stage, PD-L1 expression, resectability, and overall fitness f...

Faculty: Honey East, MD Faculty: Amir H. Hamrahian, MD Faculty: Rosario Pivonello, MD, PhD This webinar aims to give learners a case-based exploration of hypercortisolism/Cushing Syndrome (CS) care, covering screening, diagnosis, referral, and treatment. It will closely examine how to identify and screen for atypical presentations of CS, as well as approaches to managing mild cases. The program wi...

Faculty: Hanford Yau, MD, CCD, FACP, FACE Faculty: Eden Miller, DO With an updated understanding of how common hypercortisolism is among patients with hard-to-manage cardiometabolic conditions, what are the implications for clinical practice? How can healthcare providers determine who should be screened, carry out straightforward screening, and confirm a diagnosis? And once hypercortisolism is ide...

Faculty: Neeraj Agarwal, MD, FASCO Faculty: Rana McKay, MD Drs. Neeraj Agarwal and Rana McKay discuss treatment intensification strategies in metastatic castration-sensitive prostate cancer (mCSPC), with a focus on combining androgen deprivation therapy (ADT) with androgen receptor pathway inhibitors (ARPIs) and chemotherapy. They review key clinical trial data supporting doublet and triplet regim...

Faculty: Anthony Fernandez, MD, PhD Generalized pustular psoriasis (GPP) can look familiar but missing it can have serious consequences. Uncover how IL-36 signaling and immune dysregulation shape disease presentation, progression, and treatment response. You’ll learn to distinguish GPP from other neutrophilic dermatoses using clinical clues, biomarkers, and diagnostic tools. Explore how emerging t...

Faculty: Patrick Rossignol, MD, PhD Faculty: Julio Núñez, MD, PhD Iron deficiency and iron-deficiency anemia are related but distinct clinical entities, with iron deficiency often preceding or occurring independently of anemia. In chronic kidney disease (CKD), inflammation-driven iron sequestration and impaired iron availability frequently develop before hemoglobin declines, making hemoglobin-only...

Host: Jessica Allegretti, MD, MPH, FACG, AGAF Guest: Jordan E. Axelrad, MD, MPH, AGAF, FACG, FCCF Guest: Russell D. Cohen, MD, FACG, AGAF On-demand webcast on the latest advances in managing inflammatory bowel disease (IBD) and expert-informed strategies for providing guideline-concordant care to patients with IBD.

Host: Mara Fiorio, DCN, RD, LD, BC-ADM, CDCES Guest: Diana Isaacs, PharmD, BCACP, BC-ADM, CDCES, FADCES, FCCP Guest: Richard E. Pratley, MD Learn how to optimize guideline-concordant care for patients with type 2 diabetes with this on-demand webcast—featuring the latest data on weekly insulin therapies and expert-informed strategies to support the future integration of these emerging agents in you...

Host: Jamie P. Dwyer, MD Guest: J. Matthew Luther, MD, MSCI Guest: Vivek Bhalla, MD Chronic kidney disease (CKD) and high blood pressure (BP) are closely linked and, when not managed appropriately, can lead to serious outcomes such as myocardial infarction, stroke, heart failure, and progression to kidney failure. Pathological excess of aldosterone induces hypertension by forcing the kidneys to ex...

Host: Eric Merrell, MD Guest: Syed Shahzad Mustafa, MD Guest: Glenn Schneider, MD Part of the educational program Bridging Specialties®: Timely Diagnosis and Treatment for Refractory Chronic Cough , this activity explores emerging scientific insights and therapeutic advances shaping the management of refractory chronic cough (RCC). Despite appropriate evaluation and treatment of common etiologies,...

Faculty: Karen E. Anderson, MD Faculty: Hubert H. Fernandez, MD This Podcast Plus discussion examines how to distinguish tardive dyskinesia (TD) from other movement disorders using clinical features, medication timing, and response patterns. Key characteristics of TD, including irregular orofacial movements, are compared with drug-induced parkinsonism and akathisia. The discussion highlights the d...

Faculty: David T. Rubin, MD Faculty: Michael Dolinger, MD, MBA In this case-based discussion, Drs. Dolinger and Rubin examine the diagnostic approach to patients presenting with signs and symptoms suggestive of inflammatory bowel disease (IBD). The conversation explores key steps in the initial evaluation, appropriate laboratory testing, the role of colonoscopy versus additional noninvasive work-u...

Faculty: Tracy Hicks, DNP, MBA Faculty: Melissa Moody, MD Tardive dyskinesia (TD) remains significantly underdiagnosed and mismanaged despite clear guidelines. Early symptoms are often misattributed and standardized assessment tools go unused, leading to delayed detection and treatment. This ultimately contributes to substantial patient burden and is worsened by inequities in access to care, parti...

Faculty: Tracy Hicks, DNP, MBA Faculty: Melissa Moody, MD Tardive dyskinesia (TD) remains significantly underdiagnosed and mismanaged despite clear guidelines. Early symptoms are often misattributed and standardized assessment tools go unused, leading to delayed detection and treatment. This ultimately contributes to substantial patient burden and is worsened by inequities in access to care, parti...

Faculty: Tracy Hicks, DNP, MBA Faculty: Melissa Moody, MD Tardive dyskinesia (TD) remains significantly underdiagnosed and mismanaged despite clear guidelines. Early symptoms are often misattributed and standardized assessment tools go unused, leading to delayed detection and treatment. This ultimately contributes to substantial patient burden and is worsened by inequities in access to care, parti...

Faculty: Tracy Hicks, DNP, MBA Faculty: Melissa Moody, MD Tardive dyskinesia (TD) remains significantly underdiagnosed and mismanaged despite clear guidelines. Early symptoms are often misattributed and standardized assessment tools go unused, leading to delayed detection and treatment. This ultimately contributes to substantial patient burden and is worsened by inequities in access to care, parti...

Faculty: Tracy Hicks, DNP, MBA Faculty: Melissa Moody, MD Tardive dyskinesia (TD) remains significantly underdiagnosed and mismanaged despite clear guidelines. Early symptoms are often misattributed and standardized assessment tools go unused, leading to delayed detection and treatment. This ultimately contributes to substantial patient burden and is worsened by inequities in access to care, parti...

Faculty: Tracy Hicks, DNP, MBA Faculty: Melissa Moody, MD Tardive dyskinesia (TD) remains significantly underdiagnosed and mismanaged despite clear guidelines. Early symptoms are often misattributed and standardized assessment tools go unused, leading to delayed detection and treatment. This ultimately contributes to substantial patient burden and is worsened by inequities in access to care, parti...

Faculty: Tracy Hicks, DNP, MBA Faculty: Melissa Moody, MD Tardive dyskinesia (TD) remains significantly underdiagnosed and mismanaged despite clear guidelines. Early symptoms are often misattributed and standardized assessment tools go unused, leading to delayed detection and treatment. This ultimately contributes to substantial patient burden and is worsened by inequities in access to care, parti...

Faculty: Tracy Hicks, DNP, MBA Faculty: Melissa Moody, MD Tardive dyskinesia (TD) remains significantly underdiagnosed and mismanaged despite clear guidelines. Early symptoms are often misattributed and standardized assessment tools go unused, leading to delayed detection and treatment. This ultimately contributes to substantial patient burden and is worsened by inequities in access to care, parti...

Faculty: Tracy Hicks, DNP, MBA Faculty: Melissa Moody, MD Tardive dyskinesia (TD) remains significantly underdiagnosed and mismanaged despite clear guidelines. Early symptoms are often misattributed and standardized assessment tools go unused, leading to delayed detection and treatment. This ultimately contributes to substantial patient burden and is worsened by inequities in access to care, parti...

Faculty: Tracy Hicks, DNP, MBA Tardive dyskinesia (TD) remains significantly underdiagnosed and mismanaged despite clear guidelines. Early symptoms are often misattributed and standardized assessment tools go unused, leading to delayed detection and treatment. This ultimately contributes to substantial patient burden and is worsened by inequities in access to care, particularly among high-risk and...

Host: Chadwick R. Johr, MD On-demand webcast with expert insights that untangle the common myths found in Sjögren’s disease by examining its pathophysiology, common signs/symptoms, and latest data on emerging, targeted therapies.

Faculty: Jennifer Goldman, PharmD, CDCES, BC-ADM-FCCP Faculty: Francisco Javier Ampudia-Blasco, MD, PhD Continuous glucose monitoring (CGM) is still recommended for all individuals with diabetes, including those with type 2 diabetes (T2D). Despite this, its use in managing T2D has not been as widespread as expected. New evidence has recently highlighted the benefits of CGM for people with T2D. Joi...